Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1996 Jul;105(1):74–78. doi: 10.1046/j.1365-2249.1996.d01-723.x

Elevated levels of soluble CD14 in serum of patients with acute Plasmodium falciparum malaria

C WENISCH *, H WENISCH *, B PARSCHALK *, S VANIJANONTA *, H BURGMANN *, M EXNER *, K ZEDWITZ-LIEBENSTEIN *, F THALHAMMER *, A GEORGOPOULOS *, W GRANINGER *, S LOOAREESUWAN *
PMCID: PMC2200468  PMID: 8697639

Abstract

Serum sCD14, tumour necrosis factor-alpha (TNF-α), IL-6, and endotoxin were analysed in 45 patients with complicated malaria, in 14 patients with Gram-negative septicaemia and in 24 healthy subjects by ELISA. Malaria patients with renal failure (n = 16) had higher levels than patients without renal failure (n = 29) (8116+1440 μg/lversus 9453+1017 μg/lP<0.05) and both had higher levels than patients with septicaemia (6155+1635μg/l) and normal subjects (2776+747 μg/l). A significant correlation between sCD14 and IL-6 (r = 0.756) and TNF (r = 0.822) existed. However, no relation between sCD14 and serum endotoxin or indices of clinical disease severity (parasitaemia, fever, parasite or fever clearance time) was seen. Although the role of sCD14 in malaria remains to be determined, elevated levels may participate in the inflammatory response in complicated malaria.

Keywords: Plasmodium falciparum malaria, soluble CD14, septicaemia, tumour necrosis factor

Full Text

The Full Text of this article is available as a PDF (211.1 KB).


Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES